ArticleGene therapy2023
A novel preclinical model of mucopolysaccharidosis type II for developing human hematopoietic stem cell gene therapy.
Yohta Shimada et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it